$6.42
▼ -4.2% Today
as of Oct 23, 16:50 ET
Last 30 days
Recent Press Releases & News
Satellos to Participate in Upcoming Investor Conferences
Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO
Satellos Granted Composition of Matter Patent for Forazapadin
MSLE earnings at a glance
Over its last 1 reports the stock rose the next day 0 times and fell 1, moving ±2.2% on average; after the most recent report on May 15, 2026 it moved -2.2%. MSLE beat the consensus EPS estimate in 0 of its last 1 reported quarters. The share price of $6.42 sits near its 52-week low.
Overview
52-week range
$5.30
$13
14% of range
Avg surprise (last 1)
-3.9%
Avg reaction (last 1)
-2.2%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.53 | $-0.51 | -3.9% | — | -2.2% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for MSLE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
MSLE earnings FAQ
How does MSLE stock usually react to earnings?
Across the last 1 reports the average next-day move was ±2.2%, up 0 times and down 1 times.